The two researchers are among the first to address the issue of drug shortages in contexts outside of the US; their study will look at the supply of medicines in Europe, with a focus on Germany, Austria and Switzerland. The DFG will support the study through a grant valued at over 355,000 euros. The project will commence in August and will take place over the course of two years.
Shaikh and Blankart’s goal is to enable policy-makers to intervene at earlier stages of drug shortages, by developing a model that looks at potential causes. Their work will be conducted in two stages and aims to incorporate various findings and theories from different fields, including economics, management and medicine.